Schwann cells grown from human pluripotent stem cells are becoming a key tool for studying peripheral neuropathies in a human context, according to a review published in Cell & Bioscience. The article, authored by Ji-Soo Kim, Gyeong Seop Kim, Ye-Young Park, Woo-Jung Park, Keel Yong Lee and Min Seong Kim, was published on 14 October 2026 as an open access review.
Peripheral neuropathies arise from diverse genetic and acquired insults, and dysfunction of Schwann cells lies at the center of the damage they cause. When these cells fail, the result is demyelination, impaired support between axons and glia, and failed regeneration of peripheral nerves. The review argues that Schwann cells derived from human pluripotent stem cells offer a scalable and genetically defined platform for modeling these disorders in a human context.
The review surveys how these laboratory-grown Schwann cells have been applied to model specific conditions, including Charcot-Marie-Tooth disease, neurofibromatosis type 1, diabetic peripheral neuropathy, and peripheral nerve injury. It also summarizes current strategies for differentiating human pluripotent stem cells into Schwann cells, the technical foundation on which all of these disease models depend.
A central part of the analysis positions hPSC-derived Schwann cells against alternative modeling systems. The authors compare them with primary human Schwann cells, with Schwann-like cells derived from adult stem cells, and with non-human models, weighing the comparative strengths and limitations of each approach for studying peripheral nerve biology and disease.
The authors conclude that hPSC-derived Schwann cell models are becoming an important bridge between reductionist mechanistic studies and more physiologically complex peripheral nerve platforms, but that their continued value will depend on improving maturation, functional validation, multicellular integration, and translational reproducibility. As a review, the article summarizes and evaluates existing work rather than presenting new experimental findings of its own.
Subject of Research: A review of human pluripotent stem cell-derived Schwann cell models for studying peripheral neuropathies.
Article Title: Human pluripotent stem cell-derived Schwann cells for peripheral neuropathy modeling: comparative strengths, translational gaps, and emerging 3D platforms
Article References: Kim, J.-S., Kim, G. S., Park, Y.-Y., Park, W.-J., Lee, K. Y., & Kim, M. S. (2026). Human pluripotent stem cell-derived Schwann cells for peripheral neuropathy modeling: comparative strengths, translational gaps, and emerging 3D platforms. Cell & Bioscience. https://doi.org/10.1186/s13578-026-01670-4
Image Credits: AI Generated
DOI: 10.1186/s13578-026-01670-4
Keywords: Schwann cells, peripheral neuropathy, pluripotent stem cells, Charcot-Marie-Tooth disease, neurofibromatosis type 1, diabetic neuropathy, nerve injury, organoids, bioprinting, microphysiological systems, demyelination, cell differentiation
News Source: Drew Townsend. (October 28, 2026). Stem Cell-Derived Schwann Cells Emerge as a Human Model for Peripheral Neuropathy. Scienmag.



